Status:
COMPLETED
Evaluation of the Beneficial Effects of a Probiotic Product in Healthy Adult Subjects.
Lead Sponsor:
Montefarmaco OTC SpA
Conditions:
Disbiosis
Abdominal Pain
Eligibility:
All Genders
20-35 years
Phase:
NA
Brief Summary
A randomized, double-blind, placebo-controlled, cross-over trial performed at one centre in Italy to explore the ability of a multistrain probiotic mixture, to modulate markers of inflammation and int...
Eligibility Criteria
Inclusion
- Eligible subjects were healthy men and women, 20-35 years old, with a STAI scale, form Y, module 1 (state anxiety) score of ≥ 35 and ≥40, for men and women, respectively.
Exclusion
- Most important exclusion criteria were history or diagnosis of GI disease, oral antibiotics within 30 days prior to the screening visit, and use of drugs, food or herbal supplements for digestive symptoms.
Key Trial Info
Start Date :
March 23 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 18 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03234452
Start Date
March 23 2016
End Date
April 18 2017
Last Update
September 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Ricerche Cliniche di Verona Srl,
Verona, (Vr), Italy, 37100